{"abstract": "The drug, cabazitaxel, could become a new last-ditch treatment when another type of chemotherapy is no longer effective.", "web_url": "https://www.nytimes.com/2010/03/04/health/research/04cancer.html", "snippet": "The drug, cabazitaxel, could become a new last-ditch treatment when another type of chemotherapy is no longer effective.", "lead_paragraph": "A new drug being developed by Sanofi-Aventis extended the lives of men with advanced prostate cancer in a clinical trial and could become a new last-ditch treatment, researchers reported Wednesday. ", "print_section": "B", "print_page": "10", "source": "The New York Times", "multimedia": [], "headline": {"main": "Positive Test for Sanofi Prostate Cancer Drug", "kicker": null, "content_kicker": null, "print_headline": "In Trial, Drug Prolongs Lives of Men With Prostate Cancer", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Medicine and Health", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Prostate Gland", "rank": 3, "major": "N"}], "pub_date": "2010-03-03T23:09:27+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "subsection_name": "Research", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/4cdbe0b9-5036-57db-bba2-fe83b932cdfc", "word_count": 406, "uri": "nyt://article/4cdbe0b9-5036-57db-bba2-fe83b932cdfc"}